Press releases - GSK
WEBGSK announces positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) in adults with COPD. Download (PDF, 170.6KB) 03 September 2024.
GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic …
WEB6 days ago · GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a robust 13% sales growth and strategic innovations in R&D, contrasted with ...
Press releases | GSK US
WEBGSK’s THRIVE@50+ campaign with Brooke Shields encourages people aged 50 and over to discuss shingles risk and vaccination with their doctor. Download (PDF, 207.8KB) September 11 2024.
GSK's experimental drug shows promise in reducing severe …
WEBMay 21, 2024 · GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. ... Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching ...
US FDA approves GSK’s AREXVY, the world’s first respiratory …
WEBMay 3, 2023 · Issued: Philadelphia. GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved AREXVY (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.
GlaxoSmithKline News | GSK News - NewsNow
WEBGlaxoSmithKline News. NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around ...
GlaxoSmithKline (GSK) Gains FDA Clearance for First HIV Prevention ...
WEBDec 21, 2021 · GlaxoSmithKline Plc received U.S. clearance for the first long-acting injection for the prevention of HIV, a significant development for the company as it prepares to split in two next year.
GlaxoSmithKline (GSK LN) Pulls Back Inhaler Patents After US FTC ...
WEBDec 20, 2023 · GlaxoSmithKline Pulls Back Inhaler Patents After US FTC Warning Letter. Company withdraws patent listings on Advair, Flovent, Ventolin. US agency challenged 110 patent listings in FDA registry ...
GSK shares tumble after Delaware court ruling on Zantac
WEBJun 3, 2024 · GSK and the other drugmakers that sold Zantac dispute these claims. The London-listed group said it planned to appeal against the Delaware ruling. Shares in GSK were down 9.5 per cent on Monday ...
GSK’s ex-vaccines chief says its jab for a flu-like virus is too …
WEB1 day ago · Remove from myFT. GSK ex-vaccines chief says group’s blockbuster flu jab is too expensive. Emmanuel Hanon criticises former company’s vaccine after he raises $100mn for rival product. Emmanuel ...